Potential small‐molecule drugs as available weapons to fight novel coronavirus ( 2019‐nCoV ): A review-Reference-Cited by-同舟云学术

Potential small‐molecule drugs as available weapons to fight novel coronavirus ( 2019‐nCoV ): A review

Published:2020-08-17 Issue:1 Volume:39 Page:4-9
ISSN:0263-6484
Container-title:Cell Biochemistry and Function
language:en
Short-container-title:Cell Biochem Funct

Author:

Rahimkhoei Vahid¹^ORCID,Jabbari Nassrollah¹,Nourani Aynaz²,Sharifi Sina³,Akbari Ali¹^ORCID

Affiliation:

1. Solid Tumor Research Center, Research Institute for Cellular and Molecular Medicine Urmia University of Medical Sciences Urmia Iran

2. Department of Health Information Technology, School of Allied Medical Sciences Urmia University of Medical Sciences Urmia Iran

3. Disruptive Technology Laboratory, Massachusetts Eye and Ear and Schepens Eye Research Institute, Department of Ophthalmology Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,General Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbf.3576

Reference31 articles.

1. The COVID‐19 epidemic

2. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

3. Will novel virus go pandemic or be contained?

4. Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China

5. The human coronavirus HCoV-229E S-protein structure and receptor binding

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging treatment approaches for COVID-19 infection: A Critical Review;Current Molecular Medicine;2023-04-17

2. Delayed cutaneous hypersensitivity reactions following the use of infliximab or adalimumab in patients with coronavirus disease 2019;Journal of Medical Virology;2023-02

3. Potential therapeutic drug candidates against SARS-CoV-2 (COVID‐19) through molecular docking: A review;Health Science Monitor;2022-11-01

4. Therapeutic approaches and vaccination in fighting COVID-19 infections: A review;Gene Reports;2022-06

5. Newer Horizon of Mesenchymal Stem Cell–Based Therapy in the Management of SARS-CoV-2–Associated Mucormycosis: A Safe Hope for Future Medicine;Frontiers in Microbiology;2021-10-11